Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-23T16:43:23.967Z Has data issue: false hasContentIssue false

Chapter 31 - Neuroendocrine tumors and other neuroendocrine proliferations of the lung

Published online by Cambridge University Press:  05 June 2014

By
John R. Gosney
Edited by
Philip Hasleton  and
Douglas B. Flieder
Philip Hasleton
Affiliation:
University of Manchester
Douglas B. Flieder
Affiliation:
Fox Chase Cancer Center, Philadelphia
Get access

Summary

Introduction

Cells with the neuroendocrine phenotype synthesize and secrete amine or peptide hormones that regulate local physiological processes. They act in concert with systemic neural and endocrine control systems. These cells have features of both neurons and of endocrine cells, hence their name. Whether scattered as individual cells within epithelia, as in the airways or gut, or aggregated into larger structures, such as the pancreatic islets, neuroendocrine cells are characterized by their morphological uniformity and high degree of organization; that is to say, they “look” neuroendocrine. Their ultrastructural hallmark is the neurosecretory or dense core vesicles (DCVs) that store and release their secretory products (see Chapter 1). Components of these and other secretory vesicles, together with a variety of membrane proteins and enzymes, endow neuroendocrine cells with a characteristic antigenic profile. These unique features are recapitulated in the neoplasms that differentiate along neuroendocrine lines. With this particular phenotype, morphological, functional and antigenic characteristics allow such tumors to be recognized as neuroendocrine.

It is not surprising the lungs give rise to tumors characterized by neuroendocrine differentiation, since a widely dispersed and dynamic population of peptide and amine-secreting pulmonary neuroendocrine cells (PNCs) is an integral part of the respiratory epithelium (see Chapter 1). Why neuroendocrine differentiation is so common amongst pulmonary tumors is an unanswered question. The prevalence of such neoplasms in the lungs contrasts markedly with that in other epithelia, such as those lining the gastrointestinal, urinary and reproductive tracts, where neuroendocrine cells are also found, but the corresponding tumors are rare.

Type
Chapter
Information
Spencer's Pathology of the Lung , pp. 1151 - 1185
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gosney, JR.Pulmonary Endocrine Pathology: Endocrine Cells and Endocrine Tumours of the Lung. Oxford: Butterworth-Heinemann, 1992.Google Scholar
Barnard, WG.The nature of the ‘oat-celled sarcoma’ of the mediastinum. J Pathol Bacteriol 1926;29:241–4.CrossRefGoogle Scholar
Hamperl, H.Über gutartige bronchialtumoren (Cylindrome and Carcinoide). Virchows Arch Pathol 1937;300:46–88.CrossRefGoogle Scholar
Oberndorfer, S.Karzenoide tumoren des Dunndarms. Frankfurter Z Pathol 1907;1:426–32.Google Scholar
Bornstein, PN, , JP, Bernanke, D.Adrenocortical hyperfunction in association with anaplastic carcinoma of the respiratory tract. N Engl J Med 1961;264:363–71.CrossRefGoogle Scholar
Christy, NP.Adrenocorticotrophic activity in the plasma of patients with Cushing's syndrome associated with pulmonary neoplasms. Lancet 1961;1:85–6.CrossRefGoogle ScholarPubMed
Harrison, MT, Montgomery, DA, Ramsey, AS, Robertson, JH, Welbourn, RB.Cushing's syndrome with carcinoma of bronchus and with features suggesting carcinoid tumour. Lancet 1957;272:23–5.CrossRefGoogle ScholarPubMed
Bensch, KG, Corrin, B, Pariente, R, Spencer, H.Oat cell carcinoma of the lung: its origin and relationship to bronchial carcinoid. Cancer 1968;22:1163–72.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Bensch, KG, Gordon, GB, Miller, LR.Electron microscopic and biochemical studies on the bronchial carcinoid tumour. Cancer 1965;18:592–602.3.0.CO;2-6>CrossRefGoogle Scholar
Asamura, H, Kameya, T, Matsuno, Y, et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006;24:70–6.CrossRefGoogle ScholarPubMed
Brambilla, E, Lantuejoul, S.Neuroendocrine neoplasms. In Zander, DS, Farver, CF, eds. Pulmonary Pathology. Philadelphia: Churchill Livingstone, 2008. pp. 563–77.Google Scholar
Colby, TV, Koss, MN, Travis, WD.Tumors of the lower respiratory tract. In Atlas of Tumour Pathology. Washington DC: Armed Forces Institute of Pathology, 1995. pp. 287–318.Google Scholar
Franks, TJ, Galvin, JR.Lung tumors with neuroendocrine morphology: essential radiologic and pathologic features. Arch Pathol Lab Med 2008;132:1055–61.Google ScholarPubMed
Gosney, JR.Neuroendocrine tumours of the lung. Curr Diagn Pathol 2000;6:64–70.CrossRefGoogle Scholar
Gould, VE, Linnoila, RI, Memoli, VA, Warren, WH.Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias and neoplasms. Lab Invest 1983;49:519–37.Google ScholarPubMed
Gould, VE, Linnoila, RI, Memoli, VA, Warren, WH.Neuroendocrine cells and neuroendocrine neoplasms of the lung. In Sommers, SC, Rosen, PP, eds. Pathology Annual. Connecticut: Appleton Century Crofts, 1983. pp. 287–330.Google Scholar
Travis, WD.The concept of pulmonary neuroendocrine tumours. In Travis, WD, Brambilla, E, Muller-Hermelink, HK, Harris, CC, eds. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004. pp. 19–20.Google Scholar
Travis, WD, Colby, TV, Corrin, B, Shimosato, Y, Brambilla, E.Histological Typing of Lung and Pleural Tumours, 3rd ed. Berlin: Springer Verlag, 1999.CrossRefGoogle Scholar
Warren, WH, Faber, LP, Gould, VE.Neuroendocrine neoplasms of the lung: a clinicopathologic update. J Thorac Cardiovasc Surg 1989;98:321–32.Google ScholarPubMed
Warren, WH, Gould, VE, Faber, LP, Kittle, CF, Memoli, VA.Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thorac Cardiovasc Surg 1985;89:819–25.Google ScholarPubMed
Warren, WH, Memoli, VA, Gould, VE.Well differentiated and small cell neuroendocrine carcinomas of the lung. Virchows Arch B Cell Incl Mol Pathol 1988;55:299–310.Google ScholarPubMed
Wick, MR, Leslie, KO, Ritter, JH, Mills, SE.Neuroendocrine neoplasms of the lung. In Leslie, KO, Wick, MR, eds. Practical Pulmonary Pathology: A Diagnostic Approach. Philadelphia: Churchill Livingstone, 2005. pp. 423–63.Google Scholar
Flieder, DB.Neuroendocrine tumours of the lung; recent developments in histopathology. Curr Opin Pulm Med 2002;8:275–80.CrossRefGoogle ScholarPubMed
Anbazhagan, R, Tihan, T, Bornman, DM, et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res 1999;59:5119–22.Google ScholarPubMed
Barbareschi, M, Girlando, S, Mauri, FA, et al. Tumour suppressor gene products, proliferation and differentiation markers in lung neuroendocrine neoplasms. J Pathol 1992;166:343–50.CrossRefGoogle ScholarPubMed
Beasley, MB, Lantuejoul, S, Abbondanzo, S, et al. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum Pathol 2003;34:136–42.CrossRefGoogle ScholarPubMed
Brambilla, E, Negoescu, A, Gazzeri, S, et al. Apoptotis-related actors p53, Bcl2 and Bax in neuroendocrine lung tumors. Am J Pathol 1996;149:1941–52.Google Scholar
Cagle, PT, el-Naggar, AK, Xu, HJ, Hu, SX, Benedict, WF.Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. Am J Pathol 1997;150:293–400.Google ScholarPubMed
Cho, NH, Koh, ES, Lee, DW, et al. Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. J Proteome Res 2005;5:643–50.CrossRefGoogle Scholar
Gouyer, V, Gazzeri, S, Brambilla, E, et al. Loss of heterozygosity a the RB locus correlates with loss of RB protein in primary malignant neuroendocrine lung carcinomas. Int J Cancer 1994;58:818–24.CrossRefGoogle Scholar
Gugger, M, Burckhardt, E, Kappeler, A, et al. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J Pathol 2002;196:408–15.CrossRefGoogle ScholarPubMed
Hiroshima, K, Iyoda, A, Shida, T, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical and molecular analysis. Mod Pathol 2006;19:1358–68.CrossRefGoogle ScholarPubMed
Kobayashi, Y, Tokuchi, Y, Hashimoto, T, et al. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors. Cancer Sci 2004;95:334–41.CrossRefGoogle ScholarPubMed
Kovatich, A, Friedland, DM, Druck, T, et al. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer 1998;83:1109–17.3.0.CO;2-2>CrossRefGoogle ScholarPubMed
Onuki, N, Wistuba, I, Travis, WD, et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 1999;85:600–7.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Przygodzki, RM, Finkelstein, SD, Langer, JC, et al. Analysis of p53, K-ras-2 and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 1996;148:1531–41.Google ScholarPubMed
Roncalli, M, Doglioni, C, Springall, DR, et al. Abnormal p53 expression in lung neuroendocrine tumors. Diagn Mol Pathol 1992;1:129–35.CrossRefGoogle ScholarPubMed
Ullmann, R, Schwendel, A, Klemen, H, Wolf, G, Petersen, I, Popper, HH.Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization. Hum Pathol 1998;29:1145–9.CrossRefGoogle ScholarPubMed
Zaffaroni, N, De Polo, D, Villa, R, et al. Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping. J Pathol 2003;201:127–33.CrossRefGoogle ScholarPubMed
Aguayo, SM, Miller, YE, Waldron, JAJ, et al. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992;327:1285–8.CrossRefGoogle ScholarPubMed
Armas, OA, White, DA, Erlandson, RA, Rosai, J.Diffuse idiopathic neuroendocrine cell proliferation presenting as interstitial lung disease. Am J Surg Pathol 1995;19:963–70.CrossRefGoogle ScholarPubMed
Miller, RR, Muller, NL.Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 1995;19:653–8.CrossRefGoogle ScholarPubMed
Travis, WD, Brambilla, E, Muller-Hermelink, HK, Harris, CC.Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004.Google Scholar
Kreyberg, L, Liebow, AA, Uehlinger, EA.Histological Typing of Lung Tumors. International Histological Classification of Tumours No. 3. Geneva; 1967.Google Scholar
World Health Organization. The World Health Organization histological typing of lung tumours, 2nd ed. Am J Clin Pathol 1982;77:123–36.
Klimstra, DS, Modlin, IR, Adsay, NV, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic Consensus Process to the Minimum Pathology Data Set. Am J Surg Pathol 2010;34:300–13.CrossRefGoogle ScholarPubMed
Moran, CA, Suster, S, Coppola, D, Wick, MR.Neuroendocrine carcinomas of the lung. A critical analysis. Am J Clin Pathol 2009;131:206–21.CrossRefGoogle Scholar
Hofler, H.Neuroendocrine tumours of the lung. Verhandlungen Deutschen Gesell Pathol 1997;81:118–24.Google ScholarPubMed
Mosca, L, Ceresoli, A, Anzanello, E, et al. Neuroendocrine structures in normal and diseased human lung. Appl Pathol 1986;4:147–61.Google ScholarPubMed
Paladugu, RR, Benfield, JR, Pak, HY, Ross, RK, Teplitz, RL.Bronchopulmonary Kulchitzky cell carcinomas. A new classification scheme for typical and atypical carcinoids. Cancer 1985;55:1303–11.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Travis, WD, Rush, W, Flieder, DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998;22:934–44.CrossRefGoogle ScholarPubMed
Travis, WD, Gal, AA, Colby, TV, et al. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 1998;29:272–9.CrossRefGoogle ScholarPubMed
den Bakker, M, Willemsen, S, Grunberg, K, et al. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability. Histopathology 2010;56:356–63.CrossRefGoogle ScholarPubMed
Beasley, MB, Thunnissen, FB, Hasleton, PS, et al. Carcinoid tumour. In Travis, WD, Brambilla, E, Muller-Hermelink, HK, Harris, CC, eds. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004. pp. 59–62.Google Scholar
Francioni, F, Rendina, EA, Venuta, F, et al. Low grade neuroendocrine tumors of the lung (bronchial carcinoids) – 25 years experience. Eur J Cardiothorac Surg 1990;4:472–6.CrossRefGoogle ScholarPubMed
Godwin, JD.Carcinoid tumors: an analysis of 2837 cases. Cancer 1975;36:560–9.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
Wang, LT, Wilkins, EWJ, Bode, HH.Bronchial carcinoid tumors in pediatric patients. Chest 1993;103:1426–8.CrossRefGoogle ScholarPubMed
Nakhoul, F, Kerner, H, Levin, M, Best, LA, Better, OS.Carcinoid tumor of the lung and type-1 multiple endocrine neoplasia associated with persistent hypercalcaemia: a case report. Miner Electrolyte Metab 1994;20:107–11.Google ScholarPubMed
DeLellis, RD, Dayal, Y, Tischler, AS, Lee, AK, Wolfe, HJ.Multiple endocrine neoplasia (MEN) syndromes: cellular origins and inter-relationships. Int Rev Exp Pathol 1986;28:163–215.Google Scholar
Abdi, EA, Goel, R, Bishop, S, Bain, GO.Peripheral carcinoid tumours of the lung: a clinicopathologic study. J Surg Oncol 1988;39:190–6.CrossRefGoogle Scholar
Ranchod, M, Levine, GD.Spindle cell carcinoid tumors of the lung: a clinicopathologic study. J Surg Oncol 1980;4:315–31.Google ScholarPubMed
Brown, WH.A case of pluriglandular syndrome: diabetes of bearded women. Lancet 1928;2:1022–3.CrossRefGoogle Scholar
Butler, PW, Cochran, CS, Merino, MJ, et al. Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy. Pituitary 2012;15:260–5.CrossRefGoogle ScholarPubMed
Beasley, MB, Thunnissen, FB, Brambilla, E, et al. Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 2000;31:1255–65.CrossRefGoogle ScholarPubMed
Balli, M, Fabris, GA, Dewar, A, Hornall, D, Sheppard, MN.Atypical carcinoid tumor: a study of 33 cases with prognostic features. Histopathology 1994;24:363–9.Google Scholar
Mills, SE, Cooper, PH, Walker, AN, Kron, IL.Atypical carcinoid tumor of the lung. A clinicopathologic study of 17 cases. Am J Surg Pathol 1982;6:643–54.CrossRefGoogle Scholar
Warren, WH, Memoli, VA, Jordan, AG, Gould, VE.Re-evaluation of pulmonary neoplasms resected as small cell carcinomas. Significance of distinguishing between well-differentiated and small cell neuroendocrine carcinomas. Cancer 1990;65:1003–10.3.0.CO;2-Y>CrossRefGoogle Scholar
Brambilla, E, Pugatch, B, Geisinger, K, et al. Large cell carcinoma. In: Travis, WD, Brambilla, E, Muller-Hermelink, HK, Harris, CC, eds. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004. pp. 45–50.Google Scholar
Hammond, ME, Sause, WT.Large cell neuroendocrine tumours of the lung. Cancer 1985;56:1624–9.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
Iyoda, A, Hiroshima, K, Toyozaki, T, et al. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 2001;91:1992–2000.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Takei, H, Asamura, H, Maeshima, A, et al. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eight-seven cases. J Thorac Cardiovasc Surg 2002;124:285–92.CrossRefGoogle Scholar
Dresler, CM, Ritter, JH, Patterson, GA, et al. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 1997;63:180–5.CrossRefGoogle ScholarPubMed
Jiang, SX, Kameya, T, Shoji, M, Dobashi, Y, Shinada, J, Yoshimura, H.Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 1998;22:526–37.CrossRefGoogle ScholarPubMed
Mazieres, J, Daste, G, Molinier, L, et al. Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. Lung Cancer 2002;37:287–92.CrossRefGoogle ScholarPubMed
Paci, M, Cavazza, A, Annessi, V, et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg 2004;77:1163–7.CrossRefGoogle ScholarPubMed
Travis, WD, Linnoila, RI, Tsokos, MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical and flow cytometric study of 35 cases. Am J Surg Pathol 1991;15:529–53.CrossRefGoogle ScholarPubMed
Zacharias, J, Nicholson, AG, Ladas, GP, Goldstraw, P.Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg 2003;75:348–52.CrossRefGoogle ScholarPubMed
Jung, KJ, Lee, KS, Han, J, et al. Large cell neuroendocrine carcinoma of the lung: clinical, CT and pathologic findings in 11 patients. J Thorac Imaging 2001;16:156–62.CrossRefGoogle ScholarPubMed
Oshiro, Y, Kusumoto, M, Matsuno, Y, et al. CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. AJR Am J Roentgenol 2004;182:87–91.CrossRefGoogle ScholarPubMed
Demirer, T, Ravits, J, Aboulafia, D.Myasthenic (Eaton-Lambert) syndrome associated with pulmonary large cell neuroendocrine carcinoma. South Med J 1994;87:1186–9.CrossRefGoogle ScholarPubMed
Leslie, KO, Colby, TV.Pathology of lung cancer. Curr Opin Pulm Med 1997;3:252–6.CrossRefGoogle ScholarPubMed
Doll, R, Peto, R.Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 1978;32:303–13.CrossRefGoogle ScholarPubMed
Archer, VE, Saccomanno, G, Jones, JH.Frequency of different histologic types of bronchogenic carcinoma as related to radiation exposure. Cancer 1974;34:2056–60.3.0.CO;2-Z>CrossRefGoogle ScholarPubMed
Weiss, W, Moser, RL, Auerbach, O.Lung cancer in chloromethyl ether workers. Am Rev Respir Dis 1979;120:1031–7.Google ScholarPubMed
Berg, JW, Percy, C, Horn, JW.Recent change in the pattern of occurrence of oat cell carcinoma of the lung. In Magnus, K, ed. Trends in Cancer Incidence: Causes and Practical Implications. New York: Hemisphere Publishing, 1982. pp. 215.Google Scholar
Curran, WJJ.Therapy of limited stage small cell lung cancer. Cancer Treat Res 2001;105:229–52.CrossRefGoogle ScholarPubMed
Krauss, EA, Ludwig, PW, Sumner, HW.Metastatic carcinoma presenting as fulminant hepatic failure. Am J Gastroenterol 1979;72:651–4.Google ScholarPubMed
Nguyen, LN, Maor, MH, Oswald, MJ.Brain metastases as the only manifestation of an undetected primary tumor. Cancer 1998;83:2181–4.3.0.CO;2-J>CrossRefGoogle ScholarPubMed
Tritz, DB, Doll, DC, Ringenberg, QS, et al. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables. Cancer 1989;63:763–6.3.0.CO;2-F>CrossRefGoogle ScholarPubMed
Gosney, JR.The neuroendocrine lung. In Schwartz, AE, Pertsemlidis, D, Gagner, M, eds. Procedures and Techniques in Surgical Endocrinology. New York: Marcel Dekker, 2003.Google Scholar
Rassam, JW, Anderson, G.Incidence of paramalignant disorders in bronchogenic carcinoma. Thorax 1975;30:86–90.CrossRefGoogle ScholarPubMed
Thorne, NA, Transbol, I.Hyponatraemia and bronchogenic carcinoma associated with renal excretion of large amounts of antidiuretic material. Am J Med 1963;35:257–68.CrossRefGoogle Scholar
White, A, Clark, AJ.The cellular and molecular basis of the ectopic ACTH syndrome. Clin Endocrinol 1993;39:131–41.CrossRefGoogle ScholarPubMed
Croft, PB, Urich, H, Wilkinson, M.Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain 1967;90:3–66.CrossRefGoogle ScholarPubMed
Eaton, LM, Lambert, EH.Electromyography and electric stimulation of nerves in diseases of motor unit. Observations on myasthenic syndrome associated with malignant tumors. JAMA 1957;163:1117–24.CrossRefGoogle ScholarPubMed
Henson, RA, Urich, H.Cancer and the Nervous System: The Neurological Manifestations of Systemic Malignant Disease. Oxford: Blackwell, 1982.Google Scholar
Shneerson, JM.Digital clubbing and hypertrophic osteoarthropathy: the underlying mechanisms. Br J Dis Chest 1981;75:113–31.CrossRefGoogle ScholarPubMed
Chong, S, Lee, KS, Chung, MJ, et al. Neuroendocrine tumors of the lung: clinical, pathologic and Imaging findings. Radiographics 2006;26:41–57.CrossRefGoogle ScholarPubMed
Chong, S, Lee, KS, Kim, BT, et al. Integrated PET/CT of pulmonary neuroendocrine tumors: diagnostic and prognostic implications. AJR Am J Roentgenol 2007;188:1223–31.CrossRefGoogle ScholarPubMed
Erasmus, JJ, McAdams, HP, Patz, EF Jr, et al. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 1998;170:1369–73.CrossRefGoogle ScholarPubMed
Kayani, I, Bomanji, JB, Groves, A, et al. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 2008;112:2447–55.CrossRefGoogle ScholarPubMed
Kayani, I, Conry, BG, Groves, AM, et al. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors. J Nucl Med 2009;50:1927–32.CrossRefGoogle ScholarPubMed
Flieder, DB, Vazquez, VF.Lung tumors with neuroendocrine morphology: a perspective for the new millennium. Radiol Clin North Am 2000;38:563–77.CrossRefGoogle ScholarPubMed
Hasleton, PS, Al-Saffar, N.The histological spectrum of bronchial carcinoid tumors. Appl Pathol 1989;7:205–18.Google Scholar
Mark, EJ, Quay, SC, Dickersin, GR.Papillary carcinoid tumor of the lung. Cancer 1981;48:316–24.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Gosney, JR, Denley, H, Resl, M.Sustentacular cells in pulmonary neuroendocrine tumours. Histopathology 1999;34:211–5.CrossRefGoogle ScholarPubMed
Al-Kaisa, N, Abdul-Karim, FW, Mendelsohn, G, Jacobs, G.Bronchial carcinoid tumor with amyloid stroma. Arch Pathol Lab Med 1988;112:211–4.Google Scholar
Iihara, K, Yamaguchi, K, Fujioka, Y, Uno, S.Pigmented neuroendocrine tumor of the lung, showing neuromelanin. Pathol Int 2002;52:734–9.CrossRefGoogle ScholarPubMed
Szyfelbein, WM, Ross, JS.Carcinoids, atypical carcinoids and small-cell carcinomas of the lung: differential diagnosis of fine-needle aspiration biopsy specimens. Diagn Cytopathol 1988;4:1–8.CrossRefGoogle ScholarPubMed
Arrigoni, MG, Woolner, LB, Bernatz, PE.Aytpical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972;64:413–21.Google Scholar
El-Naggar, AK, Ballance, W, Karim, FW, et al. Typical and atypical bronchopulmonary carcinoids. A clinicopathologic and flow cytometric study. Am J Clin Pathol 1991;95:828–34.CrossRefGoogle ScholarPubMed
Yousem, SA.Pulmonary carcinoid tumours and well-differentiated neuroendocrine carcinomas: is there room for an atypical carcinoid?Am J Clin Pathol 1991;95:763–4.CrossRefGoogle ScholarPubMed
Yousem, SA, Taylor, SR.Typical and atypical carcinoid tumors of lung. A clinicopathologic and DNA analysis of 20 tumors. Mod Pathol 1990;3:502–7.Google Scholar
Frierson, HF, Covell, JL, Mills, SE.Fine needle aspiration cytology of atypical carcinoid of the lung. Acta Cytologica 1987;31:471–5.Google ScholarPubMed
Sturm, N, Rossi, G, Lantuejoul, S, et al. 34βE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma. Histopathology 2003;42:156–66.CrossRefGoogle ScholarPubMed
Aisner, SC, Finkelstein, DM, Ettinger, DS, et al. The clinical significance of variant-morphology small-cell carcinoma of the lung. J Clin Oncol 1990;8:402–8.CrossRefGoogle ScholarPubMed
Carter, D.Small cell carcinoma of the lung. Am J Surg Pathol 1983;7:787–95.CrossRefGoogle ScholarPubMed
Nicholson, SA, Beasley, MB, Brambilla, E, et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002;26:1184–97.CrossRefGoogle ScholarPubMed
Yesner, R.Small cell tumors of the lung. Am J Surg Pathol 1983;7:775–85.CrossRefGoogle ScholarPubMed
Azzopardi, JG.Oat-cell carcinoma of the bronchus. J Pathol Bacteriol 1959;78:513–9.CrossRefGoogle ScholarPubMed
Adelstein, DJ, Tomashefski, JF.Mixed small-cell and non-small-cell lung cancer. Chest 1986;89:699–704.CrossRefGoogle ScholarPubMed
Brambilla, E, Lanteujoul, S, Sturm, N.Divergent differentiation in neuroendocrine lung tumors. Semin Diagn Pathol 2000;17:138–48.Google ScholarPubMed
DeLellis, RA, Tischler, AS, Wolfe, HJ.Multidirectional differentiation in neuroendocrine neoplasms. J Histochem Cytochem 1984;32:899–904.CrossRefGoogle ScholarPubMed
Travis, W, Nicholson, S, Hirsch, FR, et al. Small cell carcinoma. In Travis, WD, Brambilla, E, Muller-Hermelink, HK, Harris, CC, eds. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004. pp. 31–4.Google Scholar
Frank, GA, Trakhtenberg, AK, Boguslavskii, VM.The prognosis of small cell carcinoma and malignant carcinoid of the lung. Voprosy Onkologii 1989;35:192–8.Google ScholarPubMed
Nagle, RB, Payne, CM, Clark, VA.Comparison of the usefulness of histochemistry and ultrastructural cytochemistry in the identification of neuroendocrine neoplasms. Am J Pathol 1986;85:289–96.Google ScholarPubMed
Grimelius, L.The argyrophil reaction in islet cells of adult human pancreas studied with a new silver nitrate procedure. Acta Soc Med Upsal 1968;73:271–94.Google Scholar
Masson, P.Le glande endocrine de l'intestin chez l'homme. Curr Rev Academ Sci (Paris) 1914;158:59–61.Google Scholar
Del Rio, M, Demoly, P, Koros, AM, et al. JLP5B9: new monoclonal antibody against polysialylated neural cell adhesion molecules is of value in phenotyping lung cancer. J Immunol Methods 2000;233:21–31.CrossRefGoogle ScholarPubMed
Lanteujoul, S, Moro, D, Michalides, RJ, Brambilla, C, Brambilla, E.Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 1998;22:1267–76.CrossRefGoogle Scholar
Seldeslagh, KA, Lauweryns, JM.NCAM expression in the pulmonary neural and diffuse neuroendocrine cell system. Microsc Res Tech 1997;37:69–76.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Angeletti, RH.Chromogranins and neuroendocrine secretion. Lab Invest 1986;55:387–90.Google ScholarPubMed
Eriksson, B, Arnberg, H, Lindgren, PG, et al. Neuroendocrine pancreatic tumors: clinical presentation, biochemical and histopathological findings in 84 patients. J Int Med 1990;228:103–13.CrossRefGoogle ScholarPubMed
Settleman, J, Fonseca, R, Nolan, J, Angeletti, RH.Relationship of multiple forms of chromogranin. J Biol Chem 1985;260:1645–51.Google ScholarPubMed
Tischler, AS, Mobtaker, H, Mann, K, et al. Anti-lymphocyte antibody Leu-7 (HNK-1) recognizes a constituent of neuroendocrine granule matrix. J Histochem Cytochem 1986;34:1213–6.CrossRefGoogle ScholarPubMed
Gould, VE, Lee, I, Wiedenmann, B, Moll, R, Chejfec, G, Franke, WW.Synaptophysin: a novel marker for neurons, certain neuroendocrine cells and their neoplasms. Hum Pathol 1986;17:979–83.CrossRefGoogle ScholarPubMed
Wiedenmann, B, Franke, WW.Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 1985;41:1017–28.CrossRefGoogle ScholarPubMed
Schmechel, DE, Marangos, PJB, M. Neuron specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978;276:834–6.CrossRefGoogle Scholar
Tapia, FJ, Polak, JM, Barbosa, AJ, et al. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet 1981;1:808–11.CrossRefGoogle ScholarPubMed
Carlei, F, Polak, JM.Antibodies to neuron-specific enolase for the delineation of the entire diffuse neuroendocrine system in health and disease. Semin Diagn Pathol 1984;1:59–70.Google ScholarPubMed
Haimoto, H, Takahashi, Y, Koshikawa, T, Nagura, H, Kato, K.Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 1985;52:257–63.Google ScholarPubMed
Thompson, RJ, Doran, JF, Jackson, P, Dhillon, AP, Rode, J.PGP 9.5 – a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 1983;278:224–8.CrossRefGoogle ScholarPubMed
Addis, BJ, Hamid, Q, Ibrahim, NB, et al. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung. J Pathol 1987;153:137–50.CrossRefGoogle ScholarPubMed
Borges, M, Linnoila, RI, Velde, HJ, et al. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 1997;386:852–5.CrossRefGoogle ScholarPubMed
Hiroshima, K, Iyoda, A, Shibuya, K, et al. Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Ann Thorac Surg 2002;73:1732–5.CrossRefGoogle ScholarPubMed
Jiang, SX, Kameya, T, Asamura, H, et al. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod Pathol 2004;17:222–9.CrossRefGoogle ScholarPubMed
Kahn, HJ, Marks, A, Thom, H, Baumal, R.Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol 1983;79:341–7.CrossRefGoogle ScholarPubMed
Cai, YC, Banner, B, Glickman, J, Odze, RD.Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 2001;32:1087–93.CrossRefGoogle ScholarPubMed
Battifora, H.Diagnostic uses of antibodies to keratins: a review and immunohistochemical comparison of seven monoclonal and three polyclonal antibodies. Prog Surg Pathol 1988;8:1–16.Google Scholar
Marson, VJ, Mazieres, J, Groussard, O, et al. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology 2004;45:125–34.CrossRefGoogle Scholar
Battifora, H, Silva, EG.The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma and oat cell carcinoma. Cancer 1986;58:1040–6.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Sturm, N, Rossi, G, Lantuejoul, S, et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 2002;33:175–82.CrossRefGoogle ScholarPubMed
Kaufmann, O, Dietel, M.Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology 2000;36:8–16.CrossRefGoogle ScholarPubMed
Folpe, AL, Gown, AM, Lamps, LW, et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999;12:5–8.Google ScholarPubMed
Agoff, SN, Lamps, LW, Philip, AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000;12:238–42.CrossRefGoogle Scholar
Warren, WH, Memoli, VA, Gould, VE.Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. I Carcinoids. Ultrastruct Pathol 1984;6:15–27.CrossRefGoogle ScholarPubMed
Scharifker, D, Marchevsky, A.Oncocytic carcinoid of the lung: an ultrastructural analysis. Cancer 1981;47:530–2.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Franklin, WA.Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia. Chest 2000;117:80S–9S.Google ScholarPubMed
Wick, MR, Berg, LC, Maj, MC, Hertz, MI.Large cell carcinoma of the lung with neuroendocrine differentiation. Anatom Pathol 1992;97:796–805.Google ScholarPubMed
Walch, AK, Zitzeelsberger, HF, Aubele, MM, et al. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 1998;153:1089–98.CrossRefGoogle ScholarPubMed
Debelenko, LV, Brambilla, E, Agarwal, SK, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997;6:2285–90.CrossRefGoogle ScholarPubMed
Johansson, M, Heim, S, Mandahl, N, et al. Cytogenetic analysis of six bronchial carcinoids. Cancer Genet Cytogenet 1993;66:33–28.CrossRefGoogle ScholarPubMed
Padberg, BC, Woenckhaus, J, Hilger, G, et al. DNA cytophotometry and prognosis in typical and atypical bronchopulmonary carcinoids. A clinicomorphologic study of 100 neuroendocrine lung tumors. Am J Surg Pathol 1996;29:815–22.CrossRefGoogle Scholar
D'Adda, TD, Pelosi, G, Lagrasta, C, et al. Genetic alterations in combined neuroendocrine neoplasms of the lung. Mod Pathol 2008;21:414–22.CrossRefGoogle ScholarPubMed
Hosoe, S, Shigedo, Y, Ueno, K, et al. Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung. Lung Cancer 1994;10:297–305.CrossRefGoogle ScholarPubMed
Yuan, J, Knorr, J, Altmannsberger, M, et al. Expression of p16 and lack of pRB in primary small cell lung cancer. J Pathol 1999;189:358–62.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Zabarovsky, ER, Lerman, MI, Minna, JD.Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002;21:6915–35.CrossRefGoogle ScholarPubMed
Jones, MH, Virtanen, C, Honjoh, D, et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 2004;363:775–81.CrossRefGoogle ScholarPubMed
Peng, WX, Shibata, T, Katoh, H, et al. Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung. Cancer Sci 2005;96:661–7.CrossRefGoogle ScholarPubMed
Sica, G, Wagner, PL, Altorki, N, et al. Immunohistochemical expression of estrogen and progesterone recptors in primary pulmonary neuroendocrine tumors. Arch Pathol Lab Med 2008;132:1889–95.Google Scholar
Carter, D, Yesner, R.Carcinomas of the lung with neuroendocrine differentiation. Semin Diagn Pathol 1985;2:235–54.Google ScholarPubMed
Brambilla, E, Moro, D, Veale, D, et al. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 1992;23:993–1003.CrossRefGoogle ScholarPubMed
Rossi, G, Marchioni, A, Milani, M, et al. TTF-1, cytokeratin 7, 34Eβ12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol 2004;122:884–93.CrossRefGoogle Scholar
Wick, MR.Immunohistology of neuroendocrine and neuroectodermal tumors. Semin Diagn Pathol 2000;17:194–203.Google ScholarPubMed
Marchevsky, AM, Gal, AA, Shah, S, Koss, MN.Morphometry confirms the presence of considerable nuclear size overlap between “small cells” and “large cells” in high-grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol 2001;116:466–72.CrossRefGoogle ScholarPubMed
Nitadori, J-I, Ishii, G, Tsuta, K, et al. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue mircroarray analysis with a large antibody panel. Am J Clin Pathol 2006;125:682–92.CrossRefGoogle Scholar
Sheppard, MN.Nuclear pleomorphism in typical carcinoid tumours of the lung: problems in frozen section interpretation. Histopathology 1997;30:478–80.CrossRefGoogle ScholarPubMed
Aslan, DL, Gulbahce, HE, Pambuccian, SE, Manivel, JC, Jessurun, J.Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact. Am J Clin Pathol 2005;123:874–8.CrossRefGoogle ScholarPubMed
Pelosi, G, Rodriguez, J, Viale, G, Rosai, J.Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 2005;29:179–87.CrossRefGoogle Scholar
Ferguson, MK, Landreneau, RJ, Hazelrigg, SR, et al. Long-term outcome after resection for bronchial carcinoid tumours. Eur J Cardiothorac Surg 2000;18:156–61.CrossRefGoogle Scholar
Soga, J, Yakuwa, J.Bronchopulmonary carcinoids: an analysis of 1875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999;5:211–9.Google ScholarPubMed
Goldstraw, P.Staging Manual in Thoracic Oncology. Denver: IASLC, 2009.Google Scholar
Carretta, A, Ceresoli, GL, Arrigoni, G, et al. Diagnostic and therapeutic management of neuroendocrine lung tumors: a clinical study of 44 cases. Lung Cancer 2000;29:217–25.CrossRefGoogle ScholarPubMed
Thomas, CFJ, Tazelaar, HD, Jett, JR.Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 2001;119:1143–50.CrossRefGoogle ScholarPubMed
Travis, WD, Giroux, DJ, Chansky, K, et al. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2008;3:1213–23.CrossRefGoogle ScholarPubMed
Rossi, G, Cavazza, A, Marchioni, A, et al. Role of chemotherapy and the receptor tyrosine kinases KIT PDGFRalpha, PDGFRbeta and met in large- cell neuroendocrine carcinoma of the lung. J Clin Oncol 2005;23:8774–85.CrossRefGoogle ScholarPubMed
Huang, Q, Muzitansky, A, Mark, EJ.Pulmonary neuroendocrine carcinomas: a review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification. Arch Pathol Lab Med 2002;126:545–53.Google Scholar
Asamura, H, Goya, T, Koshiishi, Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 2008;3:46–52.CrossRefGoogle ScholarPubMed
Quoix, E, Fraser, R, Wolkove, N, Finkelstein, H, Kreisman, H.Small cell lung cancer presenting as a solitary pulmonary nodule. Cancer 1990;66:577–82.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Shepherd, FA, Ginsberg, RJ, Feld, R, Evans, WK, Johansen, E.Surgical treatment for limited small-cell lung cancer: the University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg 1991;101:385–93.Google ScholarPubMed
Smit, EF, Croen, HJ, Timens, W, de Boer, WJ, Postmus, PE.Surgical resection for small cell carcinoma of the lung: a retrospective study. Thorax 1994;49:20–2.CrossRefGoogle ScholarPubMed
Sher, T, Dy, GK, Adjei, AA.Small cell lung cancer. Mayo Clin Proc 2008;83:355–67.CrossRefGoogle ScholarPubMed
Stahel, RA.Diagnosis, staging and prognostic factors of small cell lung cancer. Curr Opin Oncol 1991;3:306–11.CrossRefGoogle ScholarPubMed
Vallieres, E, Shepherd, FA, Crowley, J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:1049–59.CrossRefGoogle ScholarPubMed
Baldi, A, Groger, AM, Esposito, V, et al. Neuroendocrine differentiation in non-small cell lung carcinomas. In Vivo 2000;14:109–14.Google ScholarPubMed
Graziano, SL, Mazid, R, Newman, N, et al. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small cell lung cancer. J Clin Oncol 1989;7:1398–406.CrossRefGoogle ScholarPubMed
Loy, TS, Darkow, GVD.Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations. Am J Surg Pathol 1995;19:173–82.CrossRefGoogle Scholar
Mooi, WJ, Dewar, A, Springall, D, Polak, JM, Addis, BJ.Non-small cell lung carcinomas with neuroendocrine features. A light microscopic, immunohistochemical and ultrastructural study of 11 cases. Histopathology 1988;13:329–37.CrossRefGoogle ScholarPubMed
Schleusener, JT, Tazelaar, HD, Jung, SH, et al. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy treated non-small cell lung carcinoma. Cancer 1996;77:1284–91.3.0.CO;2-I>CrossRefGoogle Scholar
Skov, BG, Sorensen, JB, Hirsch, FR, Larsson, LI, Hansen, HH.Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma. Ann Oncol 1991;2:355–60.CrossRefGoogle ScholarPubMed
Berendsen, HH, de Leij, L, Poppema, S, et al. Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol 1989;7:1614–20.CrossRefGoogle ScholarPubMed
Carnaghi, C, Rimassa, I, Garassino, IS, A. Clinical significance of neuroendocrine phenotype in non-small cell lung cancer. Ann Oncol 2001;12:S119-S23.CrossRefGoogle ScholarPubMed
Gajra, A, Tatum, AH, Newman, N, et al. The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer. Lung Cancer 2002;36:159–65.CrossRefGoogle ScholarPubMed
Howe, MC, Chapman, A, Kerr, K, et al. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 2005;46:195–201.CrossRefGoogle ScholarPubMed
Ionescu, DN, Treaba, D, Gilks, CB, et al. Nonsmall cell lung carcinoma with neuroendocrine differentiation – an entity of no clinical or prognostic significance. Am J Surg Pathol 2007;31:26–32.CrossRefGoogle ScholarPubMed
Linnoila, RI, Piantadosi, S, Ruckdeschel, JC.Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. Chest 1994;106:367S–71S.Google ScholarPubMed
Koss, MN, Hochholzer, L, O'Leary, T.Pulmonary blastomas. Cancer 1991;67:2368–81.3.0.CO;2-G>CrossRefGoogle ScholarPubMed
Nakatani, Y, Dickersin, GR, Mark, EJ.Pulmonary endodermal tumor resembling fetal lung: a clinicopathologic study of five cases with immunohistochemical and ultrastructural characterization. Hum Pathol 1990;21:1097–107.CrossRefGoogle ScholarPubMed
Askin, FB, Rosai, J, Sibley, RK, Dehner, lP, McAlister, WH.Malignant small cell tumor of the thoracopulmonary region in childhood. Cancer 1979;43:2435–52.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Hicks, MJ, Smith, JD, Carter, AB, et al. Recurrent intrapulmonary malignant small cell tumor of the thoracopulmonary region with metastasis to the oral cavity: review of literature and case report. Ultrastruct Pathol 1995;19:297–303.CrossRefGoogle ScholarPubMed
Kahn, AG, Avagnina, A, Nazar, J, Elsner, B.Primitive neuroectodermal tumor of the lung. Arch Pathol Lab Med 2001;125:397–9.Google ScholarPubMed
Mikami, Y, Nakajima, M, Hashimoto, H, et al. Primary pulmonary primitive neuroectodermal tumor (PNET). A case report. Pathol Res Pract 2001;197:113–9.Google ScholarPubMed
Tsuji, S, Hisaoka, M, Morimitsu, Y, et al. Peripheral primitive neuroectodermal tumour of the lung: report of two cases. Histopathology 1998;33:369–74.CrossRefGoogle ScholarPubMed
Gonzalez-Crussi, F, Wolfson, SL, Misingi, K, Nakajimi, T.Peripheral neuroectodermal tumors of the chest wall in childhood. Cancer 1984;54:2519–27.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
Contesso, G, Llombart-Bosch, A, Terrier, P, et al. Does malignant small round cell tumor of the thoracopulmonary region (Askin tumor) constitute a clinicopathologic entity? Analysis of 30 cases with immunohistochemical and electron-microscopic support treated at the Institute Gustave Roussy. Cancer 1992;15:1012–20.3.0.CO;2-V>CrossRefGoogle Scholar
Schmidt, D, Herrmann, C, Jurgens, H, Harms, D.Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma – a report from the Kiel Pediatric tumor Registry. Cancer 1991;68:2251–9.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Seemayer, TA, Vekemans, M, de Chadarevian, J-P.Histological and cytogenetic findings in a malignant tumor of the chest wall and lung (Askin tumor). Virchows Arch A Pathol Anat Histopathol 1985;408:289–96.CrossRefGoogle Scholar
Ambros, IM, Ambros, PF, Strehl, S, et al. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 1991;67:1886–93.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Folpe, AL, Hill, CE, Parham, DM, O'Shea, PA, Weiss, SW.Immunohistochemical detection of FL-1 protein expression – A study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000;24:1657–62.CrossRefGoogle Scholar
Delattre, O, Zucman, J, Melot, T, et al. The Ewing family of tumors – a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294–9.CrossRefGoogle ScholarPubMed
Ordonez, NG.Desmoplastic small round cell tumor I: a histopathologic study of 39 cases with emphasis on unusual histological patterns. Am J Surg Pathol 1998;22:1303–13.CrossRefGoogle ScholarPubMed
Ordonez, NG.Desmoplastic small round cell tumor II: An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol 1998;22:1314–27.CrossRefGoogle ScholarPubMed
Hill, DA, Pfeifer, JD, Marley, EF, et al. WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study. Am J Clin Pathol 2000;114:345–53.CrossRefGoogle ScholarPubMed
Zhang, PJ, Goldblum, JR, Pawel, BR, et al. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol 2003;16:229–35.CrossRefGoogle ScholarPubMed
Chetty, R, Bhana, B, Batitang, S, Govender, D.Lung carcinoma composed of rhabdoid cells. Eur J Surg Oncol 1997;23:432–4.CrossRefGoogle ScholarPubMed
Cavazza, A, Colby, TV, Tsokos, M, Rush, W, Travis, WD.Lung tumors with a rhabdoid phenotype. Am J Clin Pathol 1996;105:182–8.CrossRefGoogle ScholarPubMed
Shimazaki, H, Aida, S, Sato, M, et al. Lung carcinoma with rhabdoid cells: a clinicopathological study and survival analysis of 14 cases. Histopathology 2001;38:425–34.CrossRefGoogle ScholarPubMed
Aubertine, CL, Flieder, DB.Primary paraganglioma of the lung. Ann Diagn Pathol 2004;8:237–41.CrossRefGoogle ScholarPubMed
Skodt, V, Jacobsen, GK, Helsted, M.Primary paraganglioma of the lung: report of two cases and review of the literature. APMIS 1995;103:597–603.CrossRefGoogle ScholarPubMed
Gosney, JR.Pulmonary neuroendocrine cell system in pediatric and adult lung disease. Microsc Res Tech 1997;37:107–13.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
Linnoila, RI.Functional facets of the pulmonary neuroendocrine system. Lab Invest 2006;86:425–44.CrossRefGoogle ScholarPubMed
Sunday, ME.Pulmonary neuroendocrine cells and lung development. Endocr Pathol 1996;7:173–201.CrossRefGoogle ScholarPubMed
Becker, KL, Nash, D, Silva, OL, Snider, RH, Moore, CF.Increased serum and urinary calcitonin levels in patients with pulmonary disease. Chest 1981;79:211–6.CrossRefGoogle ScholarPubMed
Whitwell, F.Tumourlets of the lung. J Pathol and Bacteriol 1995;1955:529–41.Google Scholar
Gosney, JR, Green, ART, Taylor, W.Appropriate and inappropriate neuroendocrine products in pulmonary tumourlets. Thorax 1990;45:679–83.CrossRefGoogle ScholarPubMed
Tsutsumi, Y, Osamura, RY, Watanabe, K, Yanaihara, N.Simultaneous histochemical localization of gastrin-releasing peptide (GRP) and calcitonin (CT) in human bronchial endocrine-type cells. Virchows Arch A Pathol Anat Histopathol 1983;400:163–71.CrossRefGoogle Scholar
Finkelstein, SD, Hasegawa, T, Colby, T, Yousem, SA.11q13 allelic imbalance discriminates pulmonary carcinoids from tumourlets. Am J Pathol 1999;155:633–40.CrossRefGoogle Scholar
Davies, SJ, Gosney, JR, Hansell, DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007;62:248–52.CrossRefGoogle Scholar
Gosney, JR, Travis, WD.Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. In Travis, WD, Brambilla, E, Muller-Hermelink, HK, Harris, CC, eds. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004. pp. 76–7.Google Scholar
Lee, JS, Brown, KK, Cool, C, Lynch, DA.Diffuse pulmonary neuroendocrine cell hyperplasia: radiologic and clinical features. J Comput Assist Tomogr 2002;26:180–4.CrossRefGoogle ScholarPubMed
Felton, WL, Liebow, AA, Lindskog, GE.Peripheral and multiple bronchial adenomas. Cancer 1953;6:555–67.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
McDowell, EM, Sorokin, SP, Hoyt, RF, Trump, BF.An unusual bronchial carcinoid tumor. Light and electron microscopy. Hum Pathol 1981;12:338–48.CrossRefGoogle ScholarPubMed
Miller, MA, Mark, GJ, Kanarek, D.Multiple peripheral pulmonary carcinoids and tumorlets of carcinoid type, with restrictive and obstructive lung disease. Am J Med 1978;65:373–8.CrossRefGoogle ScholarPubMed
Skinner, C, Ewen, SWB.Carcinoid lung: diffuse pulmonary infiltration by a multifocal bronchial carcinoid. Thorax 1976;31:212–9.CrossRefGoogle ScholarPubMed
Sorokin, SP, Hoyt, RF, McDowell, EM.An unusual bronchial carcinoid tumor analyzed by conjunctive staining. Hum Pathol 1981;12:302–13.CrossRefGoogle ScholarPubMed
Adams, H, Brack, T, Kestenholz, P, et al. Diffuse idiopathic neuroendocrine cell hyperplasia causing severe airway obstruction in a patient with a carcinoid tumor. Respiration 2006;73:690–3.CrossRefGoogle Scholar
Brown, MJ, English, J, Muller, NL.Bronchiolitis obliterans due to neuroendocrine hyperplasia: high-resolution CT-pathologic correlation. AJR Am J Roentgenol 1997;168:1561–2.CrossRefGoogle ScholarPubMed
Carmichael, MG, Zacher, LL.The demonstration of pulmonary neuroendocrine cell hyperplasia with tumorlets in a patient with chronic cough and a history of multiple medical problems. Mil Med 2005;170:439–41.CrossRefGoogle Scholar
Cohen, AJ, King, TEJ, Gilman, LB, Magill-Solc, C, Miller, YE.High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells. Am J Respir Crit Care Med 1998;158:1599–998.CrossRefGoogle ScholarPubMed
Fessler, MB, Cool, CD, Miller, YE, Schwarz, MI, Brown, KK.Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells in a patient with acromegaly. Respirology 2004;9:274–7.CrossRefGoogle Scholar
Ge, Y, Eltorky, AM, Ernst, RD, Castro, CY.Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Ann Diagn Pathol 2007;11:122–6.CrossRefGoogle ScholarPubMed
Ruffini, E, Bongiovanni, M, Cavallo, A, et al. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms. European Journal of Cardiothoracic Surgery 2004;26:165–72.CrossRefGoogle ScholarPubMed
Sheerin, N, Harrison, NK, Sheppard, MN, et al. Obliterative bronchiolitis caused by multiple tumourlets and microcarcinoids successfully treated by single lung transplantation. Thorax 1995;50:207–9.CrossRefGoogle ScholarPubMed
Darvishian, F, Ginsberg, MS, Klimstra, DS, Brogi, E.Carcinoid tumorlets simulate pulmonary metastases in women with breast cancer. Hum Pathol 2006;37:839–44.CrossRefGoogle ScholarPubMed
Du, EZ, Goldstraw, P, Zacharias, J, et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 2004;35:825–31.CrossRefGoogle ScholarPubMed
Aubry, M-C, Thomas, CF, Jett, JR, Swensen, SJ, Myers, JL.Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens. Chest 2007;131:1635–43.CrossRefGoogle ScholarPubMed
Sartelet, H, Decaussin, M, Devouassoux, G, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1 (Flt-1) and VEGF-R2 (KDR/Flk-1)) in tumorlets and in neuroendocrine cell hyperplasia of the lung. Hum Pathol 2004;35:1210–17.CrossRefGoogle ScholarPubMed
Gosney, JR, Williams, IJ, Dodson, AR, Foster, CS.Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferation and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Histopathology 2011;59:751–62.CrossRefGoogle Scholar
Sheard, JDH, Gosney, JR.Endocrine cells in tumour-bearing lungs. Thorax 1996;51:721–6.CrossRefGoogle ScholarPubMed
Rizvi, SM, Goodwill, J, Lim, E, et al. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas. Histopathology 2009;55:332–7.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×